Evidence map›Paper›PMID 39773189›Full record

ArticleCell communication and signaling : CCS2025

Polymerase delta-interacting protein 2 mediates brain vascular permeability by regulating ROS-mediated ZO-1 phosphorylation and localization at the interendothelial border.

Keke Wang, Hongyan Qu, Ruinan Hu, Bernard Lassègue, Douglas C Eaton, Chang Song, Jianjun Mu, Kathy K Griendling, Marina S Hernandes

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Keke WangDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, 1750 Haygood Dr NE, HSRB-II, Atlanta, GA, 30322, USA.
Hongyan QuDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, 1750 Haygood Dr NE, HSRB-II, Atlanta, GA, 30322, USA.
Ruinan HuDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, 1750 Haygood Dr NE, HSRB-II, Atlanta, GA, 30322, USA.
Bernard LassègueDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, 1750 Haygood Dr NE, HSRB-II, Atlanta, GA, 30322, USA.
Douglas C EatonDepartment of Medicine, Division of Nephrology, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA, 30322, USA.
Chang SongDepartment of Medicine, Division of Nephrology, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA, 30322, USA.
Jianjun MuDepartment of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Kathy K GriendlingDepartment of Medicine, Division of Nephrology, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA, 30322, USA.
Marina S HernandesDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, 1750 Haygood Dr NE, HSRB-II, Atlanta, GA, 30322, USA. mshern2@emory.edu.

Funding

Molecular mechanisms relating Poldip2 to endothelial permeabilityR01HL169373 · NHLBI · EMORY UNIVERSITY · PI Kathy K Griendling, Bernard Lassegue · 2024 to 2026
$2.1M
Poldip2 and the Brain Endothelial Barrier Function: Understanding Mechanisms that Regulate the Blood Brain Barrier IntegrityR01NS127964 · NINDS · EMORY UNIVERSITY · PI Marina Sorrentino Hernandes · 2023 to 2026
$1.7M
NHLBI NIH HHS R01 HL169373NINDS NIH HHS R01 NS127964
6 · The paper itself

Abstract

backgroundPolymerase delta-interacting protein 2 (Poldip2) is a novel regulator of vascular permeability that has been shown to be involved in aggravating blood-brain barrier (BBB) disruption following stroke; however, the underlying mechanisms are unknown. While endothelial tight junctions (TJ) are critical mediators of BBB permeability, the effect of Poldip2 on TJ function has not been elucidated yet. Here, we aim to define the mechanism by which Poldip2 mediates BBB disruption, specifically focusing on phosphorylation and stabilization of the TJ integral protein ZO-1. METHODS AND

resultsCerebral ischemia was induced in endothelial-specific Poldip2 knockout mice and controls. Cerebral vascular permeability was assessed by Evans blue dye extravasation. Endothelial-specific Poldip2 deletion abolished Evans blue dye extravasation after ischemia induction. In vitro permeability assays demonstrated that Poldip2 knockdown suppressed TNF-α-induced endothelial cell (EC) permeability. Immunofluorescence staining showed that Poldip2 depletion prevented TNF-α-induced ZO-1 disruption at interendothelial junctions. Conversely, Poldip2 overexpression increased endothelial permeability, loss of ZO-1 localization at cell-cell junctions and enhanced reactive oxygen species (ROS) production. Treatment with the antioxidant N-acetyl cysteine (NAC) reduced Poldip2-induced ZO-1 disruption at inter interendothelial junctions. Immunoprecipitation studies demonstrated Poldip2 overexpression induced tyrosine phosphorylation of ZO-1, which was prevented by treatment with NAC or MitoTEMPO, a mitochondrial ROS scavenger.

conclusionsThese data reveal a novel mitochondrial ROS-driven mechanism by which Poldip2 induces ZO-1 tyrosine phosphorylation and promotes EC permeability following cerebral ischemia.

Indexed as

Capillary PermeabilityReactive Oxygen SpeciesZonula Occludens-1 ProteinAnimalsBlood-Brain BarrierBrainBrain IschemiaEndothelial CellsHumansMiceMice, KnockoutNuclear ProteinsPhosphorylationTight JunctionsNuclear ProteinsPOLDIP2 protein, humanReactive Oxygen SpeciesZonula Occludens-1 ProteinBlood–brain barrierBrain endothelial cellsPoldip2Reactive oxygen speciesZO-1

Identifiers

PMID39773189
PMCPMC11705911

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.